Advanced Design, Development & Delivery of Skin-Mediated Therapies & Vaccines
The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug delivery systems could exceed $30 billion in 2025. The industry is on the threshold of bringing into commercial production a new generation of transformative delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed’s Microneedle Drug Delivery Systems Virtual Conference 2020 brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.